0000791908-14-000106.txt : 20140819
0000791908-14-000106.hdr.sgml : 20140819
20140819124719
ACCESSION NUMBER: 0000791908-14-000106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140814
FILED AS OF DATE: 20140819
DATE AS OF CHANGE: 20140819
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XOMA Corp
CENTRAL INDEX KEY: 0000791908
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942756657
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2910 SEVENTH ST
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5106441170
MAIL ADDRESS:
STREET 1: 2910 SEVENTH ST
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA LTD /DE/
DATE OF NAME CHANGE: 19990107
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA CORP /DE/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBIN PAUL D
CENTRAL INDEX KEY: 0001210905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14710
FILM NUMBER: 141051350
MAIL ADDRESS:
STREET 1: 37 GREYSTONE LANE
CITY: SUDBURY
STATE: MA
ZIP: 01776
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-08-14
0
0000791908
XOMA Corp
XOMA
0001210905
RUBIN PAUL D
C/O XOMA CORPORATION
2910 SEVENTH STREET
BERKELEY
CA
94710
0
1
0
0
Sr. VP Clinical Dev. & CMO
Common Shares
2014-08-14
4
M
0
26748
0
A
98769
D
Common Shares
2014-08-15
4
S
0
10299
4.3054
D
88470
D
Common Shares
2014-08-18
4
S
0
16449
4.3621
D
72021
D
Common Shares
5310
I
by 401(k)
Restricted Stock Units
0
2014-08-14
4
M
0
26748
0
D
2015-08-14
Common Shares
26748
26748
D
These restricted stock units are scheduled to vest in substantially equal installments annually over three years, with the first installment vesting on August 14, 2013.
Shares sold on the open market to satisfy the minimum amount of taxes required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's equity incentive plan.
This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2014.
This transaction was executed in multiple trades ranging at prices from $4.32 to $4.41.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
By: Russell J. Wood For: Paul D. Rubin
2014-08-18